ProfileGDS4718 / 224830_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 81% 93% 81% 88% 95% 96% 86% 84% 90% 90% 88% 91% 94% 93% 91% 91% 96% 93% 88% 88% 88% 87% 89% 90% 96% 86% 94% 84% 94% 92% 94% 81% 84% 94% 96% 89% 86% 84% 94% 87% 96% 93% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4906185
GSM549102patient 115, normal, homogenized [OPG study]7.8693881
GSM549104patient 119, normal, homogenized [OPG study]9.8470793
GSM549108patient 138, normal, homogenized [OPG study]7.9104981
GSM549119patient 077, normal, homogenized [OPG study]8.9492588
GSM549133patient 032, cancer, homogenized [OPG study]10.220795
GSM549139patient 042, cancer, homogenized [OPG study]10.546496
GSM549099patient 107, normal, homogenized [OPG study]8.5546286
GSM549109patient 139, normal, homogenized [OPG study]8.3087184
GSM549110patient 046, normal, homogenized [OPG study]9.2910590
GSM549114patient 063, normal, homogenized [OPG study]9.3006390
GSM549122patient 082, normal, homogenized [OPG study]8.8390388
GSM549134patient 033, cancer, homogenized [OPG study]9.31791
GSM549136patient 036, cancer, homogenized [OPG study]10.062994
GSM549140patient 044, cancer, homogenized [OPG study]9.7803493
GSM549111patient 047, normal, homogenized [OPG study]9.5401491
GSM549113patient 057, normal, homogenized [OPG study]9.5906191
GSM549132patient 031, cancer, homogenized [OPG study]10.383796
GSM549137patient 038, cancer, homogenized [OPG study]9.741193
GSM549142patient 047, cancer, homogenized [OPG study]8.4943888
GSM549100patient 110, normal, homogenized [OPG study]8.8754288
GSM549107patient 135, normal, homogenized [OPG study]8.8819488
GSM549115patient 068, normal, homogenized [OPG study]8.9298987
GSM549116patient 072, normal, homogenized [OPG study]9.0761489
GSM549120patient 078, normal, homogenized [OPG study]9.2763990
GSM549131patient 030, cancer, homogenized [OPG study]10.440996
GSM549118patient 074, normal, homogenized [OPG study]8.7029886
GSM549129patient 027, cancer, homogenized [OPG study]9.8804694
GSM549123patient 088, normal, homogenized [OPG study]8.3615584
GSM549124patient 006, cancer, homogenized [OPG study]9.6859194
GSM549126patient 015, cancer, homogenized [OPG study]9.4424192
GSM549128patient 025, cancer, homogenized [OPG study]9.9111694
GSM549103patient 117, normal, homogenized [OPG study]7.8175981
GSM549117patient 073, normal, homogenized [OPG study]8.396484
GSM549138patient 041, cancer, homogenized [OPG study]9.9350194
GSM549141patient 045, cancer, homogenized [OPG study]10.635596
GSM549130patient 028, cancer, homogenized [OPG study]9.0014989
GSM549101patient 111, normal, homogenized [OPG study]8.5991286
GSM549105patient 128, normal, homogenized [OPG study]8.3233784
GSM549106patient 134, normal, homogenized [OPG study]10.059994
GSM549112patient 048, normal, homogenized [OPG study]8.8246787
GSM549125patient 011, cancer, homogenized [OPG study]10.597996
GSM549127patient 024, cancer, homogenized [OPG study]9.5923593
GSM549135patient 035, cancer, homogenized [OPG study]9.7535593